Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of graft sources on allogeneic hematopoietic stem cell transplantation outcome in adults with chronic myeloid leukemia in the era of tyrosine kinase inhibitors: a Japanese Society of Hematopoietic Cell Transplantation retrospective analysis.
Ohashi K, Nagamura-Inoue T, Nagamura F, Tojo A, Miyamura K, Mori T, Kurokawa M, Taniguchi S, Ishikawa J, Morishima Y, Atsuta Y, Sakamaki H. Ohashi K, et al. Among authors: nagamura f, nagamura inoue t. Int J Hematol. 2014 Sep;100(3):296-306. doi: 10.1007/s12185-014-1632-9. Epub 2014 Aug 2. Int J Hematol. 2014. PMID: 25085253
Clinical impact of pretransplant use of multiple tyrosine kinase inhibitors on the outcome of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia.
Kondo T, Nagamura-Inoue T, Tojo A, Nagamura F, Uchida N, Nakamae H, Fukuda T, Mori T, Yano S, Kurokawa M, Ueno H, Kanamori H, Hashimoto H, Onizuka M, Takanashi M, Ichinohe T, Atsuta Y, Ohashi K. Kondo T, et al. Among authors: nagamura f, nagamura inoue t. Am J Hematol. 2017 Sep;92(9):902-908. doi: 10.1002/ajh.24793. Epub 2017 Jun 9. Am J Hematol. 2017. PMID: 28543934 Free article. Clinical Trial.
Autologous bone marrow transplantation for patients with advanced chronic myelogenous leukemia.
Nagamura-Inoue T, Tojo A, Ikebuchi K, Takahashi S, Ogura H, Shindoh E, Nagamura F, Uemura N, Watari K, Irie S, Setoyama M, Tajika K, Nakayama M, Nagayama H, Kobayashi Y, Shirafuji N, Sato N, Okamoto S, Ozawa K, Tani K, Asano S. Nagamura-Inoue T, et al. Among authors: nagamura f. Int J Hematol. 1997 Dec;66(4):493-503. doi: 10.1016/s0925-5710(97)00067-4. Int J Hematol. 1997. PMID: 9479875
Using related donors other than genotypically HLA-matched siblings in allogeneic hematopoietic stem cell transplantation for hematologic disease: a single institution experience in Japan.
Tomonari A, Iseki T, Ooi J, Takahashi S, Ishii K, Takahashi T, Shindo M, Nagamura F, Uchimaru K, Nagayama H, Shirafuji N, Tojo A, Tani K, Asano S. Tomonari A, et al. Among authors: nagamura f. Int J Hematol. 2002 Nov;76(4):354-9. doi: 10.1007/BF02982696. Int J Hematol. 2002. PMID: 12463600 Clinical Trial.
Immunological influence of serum-free manufactured umbilical cord-derived mesenchymal stromal cells for steroid-resistant acute graft-versus-host disease.
Nagamura-Inoue T, Kato S, Najima Y, Isobe M, Doki N, Yamamoto H, Uchida N, Takahashi A, Hori A, Nojima M, Ohashi K, Nagamura F, Tojo A. Nagamura-Inoue T, et al. Among authors: nagamura f. Int J Hematol. 2022 Nov;116(5):754-769. doi: 10.1007/s12185-022-03408-7. Epub 2022 Jul 30. Int J Hematol. 2022. PMID: 35908021 Clinical Trial.
52 results